Abstract | STUDY OBJECTIVE: DESIGN: Prospective, randomized, double-blinded, placebo-controlled trial. SETTING: Operating room. PATIENTS: Seventy-four ASA I-II female patients scheduled for thyroid cancer surgery were included to the study. INTERVENTIONS: Patients were randomly allocated to receive pre-operative ultrasound-guided bilateral SCPB with 10 ml of ropivacaine 0.5% or normal saline on each side. MEASUREMENTS: MAIN RESULTS: The global QoR-15 score at 24 h postoperatively was significantly higher in the SCPB group (Median [IQR], 118 [115-120]) than the control group (110 [106-112]) with a median difference of 8 (95% CI: 6 to 10, P < .001). Compared with the control group, pre-operative ultrasound-guided bilateral SCPB reduced postoperative pain up to 24 h and the incidence of PONV, as well as the length of PACU stay. Additionally, the patient satisfaction scores were improved in the SCPB group (P = .024). CONCLUSION: Pre-operative ultrasound-guided bilateral SCPB with ropivacaine enhances the quality of recovery, postoperative analgesia and patient satisfaction, alleviates the incidence of PONV, and accelerates the PACU discharge following thyroid cancer surgery.
|
Authors | Yusheng Yao, Cailing Lin, Qiaolan He, Hongxin Gao, Lufen Jin, Xiaochun Zheng |
Journal | Journal of clinical anesthesia
(J Clin Anesth)
Vol. 61
Pg. 109651
(May 2020)
ISSN: 1873-4529 [Electronic] United States |
PMID | 31761416
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2019 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Anesthetics, Local
- Cervical Plexus Block
(adverse effects)
- Double-Blind Method
- Female
- Humans
- Nerve Block
(adverse effects)
- Pain Measurement
- Pain, Postoperative
(epidemiology, etiology, prevention & control)
- Prospective Studies
- Thyroid Neoplasms
(surgery)
- Ultrasonography, Interventional
|